4//SEC Filing
Ohr Pharmaceutical Inc 4
Accession 0001387131-17-002049
CIK 0001173281operating
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 12:59 PM ET
Size
7.6 KB
Accession
0001387131-17-002049
Insider Transaction Report
Form 4
Backenroth Samuel
CEO & VP of Bus. Development
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2017-04-10$0.70/sh+71,429$50,000→ 212,596 total - Purchase
Warrants (right to buy)
2017-04-10+50,001→ 50,001 totalExercise: $1.00From: 2017-04-10Exp: 2022-04-10→ Common Stock (50,001 underlying)
Footnotes (1)
- [F1]On April 5, 2017, Ohr Pharmaceutical, Inc. (the "Issuer") entered into a securities purchase agreement (the "Securities Purchase Agreement") with various purchasers set forth on the signatures pages thereto, including the Reporting Person. Pursuant to the Securities Purchase Agreement, the Reporting Person purchased shares of the Issuer's common stock (the "Common Stock") and warrants to purchase shares of Common Stock in a registered offering (the "Offering") for an aggregate purchase price of $50,000.03. The closing of the Offering occurred on April 10, 2017.
Documents
Issuer
Ohr Pharmaceutical Inc
CIK 0001173281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001173281
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 12:59 PM ET
- Size
- 7.6 KB